MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • The Representativity of PSP patients included in clinical trials

    LL. Mariani, R. Guimarães-Costa, D. Grabli, B. Letoullec, F. Cormier, B. Degos, B. Dubois, M. Vidailhet, L. Lacomblez, JC. Corvol (Paris, France)

  • The right hemisphere inhibitory network in patients with asymmetrical Parkinson’s disease: An fMRI study

    F. Lazoya, I. Obeso, R. Gonzales Redondo, F. Villagra, E. Luis, J. Obeso, M. Jahanshahi, M. Pastor (Pamplona, Spain)

  • The Roche HD Natural History Study – an external comparator by design

    G. Hooper, G. Palermo, F. Hlavac, C. Finnegan, E. Frick, L. Boak, R. Doody, S. Schobel (Welwyn Garden City, United Kingdom)

  • The role of attention in functional movement disorders

    A. Huys, P. Haggard, K. Bhatia, M. Edwards (London, United Kingdom)

  • The role of Dopamine in Preparatory Inhibition: What can we learn from Parkinson’s disease?

    E. Wilhelm, C. Quoilin, G. Derosiere, A. Jeanjean, J. Duqué (Brussels, Belgium)

  • The role of dysfunctional attentional processing in isolated minor hallucinations in Parkinson’s disease

    H. Bejr-Kasem, J. Pagonabarraga, S. Martínez-Horta, F. Ruiz-Martínez, F. Bernasconi, F. Sampedro, J. Marín-Lahoz, A. Horta-Barba, I. Aracil-Bolaños, B. Pascual-Sedano, O. Blanke, J. Kulisevsky (Barcelona, Spain)

  • The Role of Dysfunctional BDNF in Remodeling the Parkinsonian Striatum Following Dopamine Neuron Grafting in CRISPR rs6265 Rats

    N. Mercado, J. Stancati, T. Collier, C. Sortwell, I. Sandoval, C. Kemp, B. Daley, M. Duffy, K. Steece-Collier (Grand Rapids, MI, USA)

  • The Role of Environmental Toxins (Rotenone) in Parkinson’s Disease

    Z. Akbarkhodjaeva, DJ. Tursunov (Tashkent, Uzbekistan)

  • The role of genetic modifiers in Parkinson’s disease-associated LRRK2-G2019S mutation

    T. Courtin, G. Ianello, H. Bertrand, S. Benromdhan, C. Tesson, C. Mhiri, JC. Corvol, S. Lesage, A. Brice (Paris, France)

  • The role of lipid metabolism in mouse models of Parkinson’s disease

    M. Trabjerg, D. Andersen, P. Huntjens, K. Mørk, M. Skjønnemand, M. Oklinski, A. Mørkholt, I. Huijbers, C. Pritchard, L. Kroese, J. Nieland (Aalborg, Denmark)

  • « Previous Page
  • 1
  • …
  • 199
  • 200
  • 201
  • 202
  • 203
  • …
  • 217
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley